Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial
Results on March 4, 2014
- Conference Call and Webcast at 4:30 p.m. Eastern Time -
SEATTLE, Feb. 25, 2014
SEATTLE, Feb. 25, 2014 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ
and MTA: CTIC) announced today that it will report its fourth quarter and full
year 2013 financial results on Tuesday, March 4, 2014, after the close of the
U.S. financial markets. Following the announcement, members of the management
team will host a webcast conference call to discuss the results and provide a
general corporate update at 4:30 p.m. ET (1:30 p.m. PT). Access to the event
can be obtained as follows:
Tuesday, March 4
1:30 p.m. PT/4:30 p.m. ET/10:30 p.m. CET
1-800-762- 8779 (domestic)
+1 480-629-9771 (international)
To access the live audio webcast or the subsequent archived recording, visit
CTI's website, www.celltherapeutics.com. Webcast and telephone replays of the
conference call will be available at approximately two hours after completion
of the call. Callers can access the replay by dialing 1-800-406-7325
(domestic) or +1 303-590-3030 (international). The access code for the replay
is #4670750. The telephone replay will be available untilTuesday, March 11,
About Cell Therapeutics, Inc.
CTI (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the
development and commercialization of an integrated portfolio of oncology
products aimed at making cancer more treatable. CTI is headquartered in
Seattle, WA. For additional information and to sign up for email alerts and
get RSS feeds, please visit www.CellTherapeutics.com.
CTI Life Sciences Limited, Milan Branch
+39 02 89659706
SOURCE Cell Therapeutics, Inc.
Press spacebar to pause and continue. Press esc to stop.